Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHASE-III TRIAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 289 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Psyrri, A; Murren, J
      Small cell lung cancer: Strategies to optimize chemotherapy response

      CANCER JOURNAL
    2. Buchner, T; Hiddemann, W; Schoch, C; Haferlach, T; Sauerland, MC; Heinecke, A
      Acute myeloid leukaemia (AML): treatment of the older patient

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    3. Chodak, GW; Kolvenbag, GJCM
      Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?

      PROSTATE CANCER AND PROSTATIC DISEASES
    4. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Ghaneh, P; Slavin, J; Sutton, R; Hartley, M; Neoptolemos, JP
      Adjuvant therapy in pancreatic cancer

      WORLD JOURNAL OF GASTROENTEROLOGY
    6. Huncharek, M; Caubet, JF; McGarry, R
      Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials

      MELANOMA RESEARCH
    7. Twelves, C; Boyer, M; Findlay, M; Cassidy, J; Weitzel, C; Baker, C; Osterwalder, B; Jamieson, C; Hieke, K
      Capecitabine (Xeloda (TM)) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients withadvanced colorectal carcinoma

      EUROPEAN JOURNAL OF CANCER
    8. Eggermont, AMM
      The role interferon-alpha in malignant melanoma remains to be defined

      EUROPEAN JOURNAL OF CANCER
    9. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    10. Sause, WT
      Nonsurgical management of non-small-cell lung cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    11. Rowe, JM
      Uncertainties in the standard care of acute myelogenous leukemia

      LEUKEMIA
    12. Sandblom, G; Varenhorst, E
      Incidence rate and management of prostate carcinoma

      BIOMEDICINE & PHARMACOTHERAPY
    13. Goss, PE; Strasser, K
      Aromatase inhibitors in the treatment and prevention of breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    14. Lee, ST; Jang, JH; Suh, HC; Hahn, JS; Ko, YW; Min, YH
      Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

      AMERICAN JOURNAL OF HEMATOLOGY
    15. Curran, WJ; Ajani, J; Ang, K; Bonanni, R; Bruner, D; Byhardt, R; Eisenberg, B; Gillin, MT; Ginsberg, RJ; Greven, K; Grignon, D; Hammond, E; Layne, E; McCormick, B; Mehta, M; Michalski, J; Okunieff, P; Sandler, H; Scarantino, CW; Willett, C
      Radiation Therapy Oncology Group, research plan 2002-2006

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    16. Sim, S; Rosenzweig, KE; Schindelheim, R; Ng, KK; Leibel, SA
      Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    17. Tyldesley, S; Boyd, C; Schulze, K; Walker, H; Mackillop, WJ
      Estimating the need for radiotherapy for lung cancer: An evidence-based, epidemiologic approach

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    18. Ahn, JB; Shim, KY; Jeung, HC; Rha, SY; Yoo, NC; Kim, NK; Roh, JK; Min, JS; Kim, BS; Chung, HC
      Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer

      CANCER LETTERS
    19. Cabrera, J; Munoz, J; Sanchez, J
      Current trends in the treatment of locally advanced non-small cell bronchopulmonary carcinoma

      ARCHIVOS DE BRONCONEUMOLOGIA
    20. Bergh, J; Jonsson, PE; Glimelius, B; Nygren, P
      A systematic overview of chemotherapy effects in breast cancer

      ACTA ONCOLOGICA
    21. Ragnhammar, P; Hafstrom, L; Nygren, P; Glimelius, B
      A systematic overview of chemotherapy effects in colorectal cancer

      ACTA ONCOLOGICA
    22. Janinis, J; Papadakou, M; Panagos, G; Panousaki, A; Georgoulias, V; Hatzidaki, D; Lefantzis, D; Dokianakis, G
      Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracilin patients with locally advanced head and neck cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    23. Komaki, R; Chasen, MH; Travis, WD; Putnam, JB; Fossella, FV; Byhardt, RW; Ro, JY
      Oncodiagnosis panel: 1999 cancer of the lung: Oncodiagnosis

      RADIOGRAPHICS
    24. Falk, MH; Issels, RD
      Hyperthermia in oncology

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    25. Kato, T; Shimamoto, Y; Uchida, J; Ohshimo, H; Abe, M; Shirasaka, T; Fukushima, M
      Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil

      ANTICANCER RESEARCH
    26. Lin, CC; Hsu, CH; Chen, J; Tsai, TC; Cheng, AL; Pu, YS
      A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer

      ANTICANCER RESEARCH
    27. Ampil, FL; Mills, GM; Stucker, FJ; Burton, GV; Nathan, CAO
      Radical combined treatment of locally extensive head and neck cancer in the elderly

      AMERICAN JOURNAL OF OTOLARYNGOLOGY
    28. Sauer, R; Fietkau, R; Wittekind, C; Martus, P; Rodel, C; Hohenberger, W; Jatzko, G; Sabitzer, H; Karstens, JH; Becker, H; Hess, C; Raab, R
      Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer - A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94)

      STRAHLENTHERAPIE UND ONKOLOGIE
    29. Kotas, M; Willner, J; Flentje, M
      Sequential chemo-radiotherapy in non-small cell lung cancer

      LUNG CANCER
    30. Fietkau, R
      Concomitant radiochemotherapy of advanced non-small-cell lung cancer

      LUNG CANCER
    31. Thomas, M; Broermann, P; Droege, C; Lerchenmuller, C; Berdel, WE
      Development of treatment strategies in locally advanced non-small cell lung cancer (take home messages)

      LUNG CANCER
    32. Schuette, W
      Chemotherapy as treatment of primary and recurrent small cell lung cancer

      LUNG CANCER
    33. D'Incan, M; Souteyrand, P
      Dacarbazine (Deticene (R))

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    34. Jansman, FGA; Sleijfer, DT; de Graaf, JC; Coenen, JLLM; Brouwers, JRBJ
      Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer

      DRUG SAFETY
    35. Schiller, JH
      Current standards of care in small-cell and non-small-cell lung cancer

      ONCOLOGY
    36. Reneses, S; Pestana, L
      Systematic review of clinical trials on the treatment of rheumatoid arthritis with tumour necrosis factor alpha (TNF alpha) inhibitors

      MEDICINA CLINICA
    37. Pantuck, AJ; Zisman, A; Belldegrun, AS
      The changing natural history of renal cell carcinoma

      JOURNAL OF UROLOGY
    38. Minsky, BD
      UFT (R) plus oral leucovorin calcium (Orzel (TM)) and radiation in combined modality therapy: A comprehensive review

      INTERNATIONAL JOURNAL OF CANCER
    39. Cortes, J; Estey, E; O'Brien, S; Giles, F; Shen, Y; Koller, C; Beran, M; Thomas, D; Keating, M; Kantarjian, H
      High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia

      CANCER
    40. Bardet, E; Moro-Sibilot, D; Le Chevalier, T; Massard, G; Douillard, JY; Theobald, S; Astoul, P; Baldeyrou, P; Bazelly, B; Brechot, J; Breton, JL; Grivaux, M; Jacoulet, P; Khalil, A; Lemarie, E; Martinet, Y; Milleron, B; Paesmans, M; Pujol, JL; Quoix, AE; Ranfaing, E; Riviere, A; Sancho-Garnier, H; Souquet, PJ; Spaeth, D; Stoebner-Delbarre, A; Thiberville, L; Touboul, E; Vaylet, F; Vergnon, JM; Westeel, V; Depierre, A; Lagrange, JL
      Standards, Options and Recommendations for the management of locally advanced non small cell lung carcinoma

      BULLETIN DU CANCER
    41. Matthews, JP; Bishop, JF; Young, GAR; Juneja, SK; Lowenthal, RM; Garson, OM; Cobcroft, RG; Dodds, AJ; Enno, A; Gillett, EA; Hermann, RP; Joshua, DE; Ma, DD; Szer, J; Taylor, KM; Wolf, M; Bradstock, KF
      Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    42. Dumontet, C; Morschhauser, F; Solal-Celigny, P; Bouafia, F; Bourgeois, E; Thieblemont, C; Leleu, X; Hequet, O; Salles, G; Coiffier, B
      Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma

      BRITISH JOURNAL OF HAEMATOLOGY
    43. Focan, C; Beauduin, M; Salamon, E; de Greve, J; de Wasch, G; Lobelle, JP; Majois, F; Tagnon, A; Tytgat, J; van Belle, S; Vandervellen, R; Vindevoghel, A
      Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13years update in a multicentre randomized trial

      BRITISH JOURNAL OF CANCER
    44. Thirion, P; Piedbois, P; Buyse, M; O'Dwyer, PJ; Cunningham, D; Man, A; Greco, FA; Colucci, G; Kohne, CH; Di Costanzo, F; Piga, A; Palmeri, S; Dufour, P; Cassano, A; Pajkos, G; Pensel, R; Aykan, NF; Marsh, J; Seymour, T
      Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer

      BRITISH JOURNAL OF CANCER
    45. Hale, A; Azorin, JM; Kasper, S; Maier, W; Syvalahti, E; Van der Burght, M; Sloth-Nielsen, M; Wehnert, A
      Sertindole is associated with a low level of extrapyramidal symptoms in schizophrenic patients: Results of a phase III trial

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    46. Hale, A; Azorin, JM; Kasper, S; Maier, W; Syvalahti, E; Van der Burght, M; Sloth-Nielsen, M; Wehnert, A
      Sertindole improves both the positive and negative symptoms of schizophrenia: Results of a phase III trial

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    47. Lingen, MW; Emami, B; Clark, JI
      New therapeutic strategies for the treatment and prevention of head and neck cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    48. Royce, ME; Hoff, PM; Pazdur, R
      Progress in colorectal cancer chemotherapy - How far have we come, how farto go?

      DRUGS & AGING
    49. Adelstein, DJ
      The role of chemotherapy for skull base carcinomas and sarcomas

      NEUROSURGERY CLINICS OF NORTH AMERICA
    50. Lee, ML; Tomsu, K; Von Eschen, KB
      Duration of survival for disseminated malignant melanoma: results of a meta-analysis

      MELANOMA RESEARCH
    51. Dranitsaris, G; Leung, P; Mather, J; Oza, A
      Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate

      ANTI-CANCER DRUGS
    52. Osoba, D
      Health-related quality-of-life assessment in clinical trials of supportivecare in oncology

      SUPPORTIVE CARE IN CANCER
    53. Ohno, R
      How high can we increase complete remission rate in adult acute myeloid leukemia?

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    54. Bleeker, WA; Mulder, NH; Hermans, J; Otter, R; Plukker, JT
      The addition of low-dose leucovorin to the combination of 5-fluorouracil-levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer

      ANNALS OF ONCOLOGY
    55. Eberhardt, W; Bildat, S; Korfee, S
      Combined modality therapy in NSCLC

      ANNALS OF ONCOLOGY
    56. Ardizzoni, A; Grossi, F
      Update on the treatment of small cell lung cancer (SCLC)

      ANNALS OF ONCOLOGY
    57. Balducci, L; Corcoran, MB
      Antineoplastic chemotherapy of the older cancer patient

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    58. Gaynon, PS; Bostrom, BC; Hutchinson, RJ; Lange, BJ; Nachman, JB; Steinherz, PG; Sensel, MG; Lee, MK; Stram, DO; Sather, HN
      Duration of hospitalization as a measure of cost on childrens cancer groupacute lymphoblastic leukemia studies

      JOURNAL OF CLINICAL ONCOLOGY
    59. Vokes, EE; Kies, MS; Haraf, DJ; Stenson, K; List, M; Humerickhouse, R; Dolan, ME; Pelzer, H; Sulzen, L; Witt, ME; Hsieh, YC; Mittal, BB; Weichselbaum, RR
      Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

      JOURNAL OF CLINICAL ONCOLOGY
    60. Temam, S; Flahault, A; Perie, S; Monceaux, G; Coulet, F; Callard, P; Bernaudin, JF; St Guily, JL; Fouret, P
      p53 gene status as a predictor of tumor response to induction chemotherapyof patients with locoregionally advanced squamous cell carcinomas of the head and neck

      JOURNAL OF CLINICAL ONCOLOGY
    61. Schroder, FH; van den Ouden, D
      Management of locally advanced prostate cancer - 2. Radiotherapy, neoadjuvant endocrine treatment, update 1997-1999

      WORLD JOURNAL OF UROLOGY
    62. Kornek, GV; Schratter-Sehn, AU; Burian, M
      Locally advanced head and neck cancer: Modern concepts for therapy

      ONKOLOGIE
    63. Koukourakis, MI; Giatromanolaki, A; Sivridis, E; Fezoulidis, I
      Cancer vascularization: Implications in radiotherapy?

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    64. Trotti, A
      Toxicity in head and neck cancer: A review of trends and issues

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    65. Stockler, M; Wilcken, NRC; Ghersi, D; Simes, RJ
      Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer

      CANCER TREATMENT REVIEWS
    66. Adams, VR
      Adverse events associated with chemotherapy for common cancers

      PHARMACOTHERAPY
    67. Reif, MS; Socinski, MA; Rivera, MP
      Evidence-based medicine in the treatment of non-small-cell lung cancer

      CLINICS IN CHEST MEDICINE
    68. Cochran, AJ; Bhuta, S; Paul, E; Ribas, A
      The shifting patterns of metastatic melanoma

      CLINICS IN LABORATORY MEDICINE
    69. Maurel, J; Martinez-Trufero, J; Artal, A; Martin, C; Puertolas, T; Zorrrilla, M; Herrero, A; Anton, A; Rosell, R
      Prognostic impact of bulky mediastinal lymph nodes (N2 > 2.5 cm) in patients with locally advanced non-small-cell lung cancer (LA-NSCLC) treated withplatinum-based induction chemotherapy

      LUNG CANCER
    70. Biedermann, B; Landmann, C; Kann, R; Passweg, J; Soler, M; Lohri, A; Rochlitz, C; Herrmann, R; Pless, M
      Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer

      RADIOTHERAPY AND ONCOLOGY
    71. Guelfi, JD; Strub, N; Loft, H
      Efficacy of intravenous citalopram compared with oral citalopram for severe depression - Safety and efficacy data from a double-blind, double-dummy trial

      JOURNAL OF AFFECTIVE DISORDERS
    72. Jansman, FGA; Sleijfer, DT; Coenen, JLLM; De Graaf, JC; Brouwers, JRBJ
      Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer

      DRUG SAFETY
    73. Leahey, AM; Bunin, NJ; Belasco, JB; Meek, R; Scher, C; Lange, BJ
      Novel multiagent chemotherapy for bone marrow relapse of pediatric acute lymphoblastic leukemia

      MEDICAL AND PEDIATRIC ONCOLOGY
    74. Forastiere, AA
      Head and neck cancer: Overview of recent developments and future directions

      SEMINARS IN ONCOLOGY
    75. Posner, MR; Colevas, AD; Tishler, RB
      The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck

      SEMINARS IN ONCOLOGY
    76. McLeod, DG; Iversen, P
      Gynecomastia in patients with prostate cancer: A review of treatment options

      UROLOGY
    77. Keilholz, U; Eggermont, AMM
      The emerging role of cytokines in the treatment of advanced melanoma

      ONCOLOGY
    78. Johnson, DH
      Locally advanced, unresectable non-small cell lung cancer - New treatment strategies

      CHEST
    79. Sause, W; Kolesar, P; Taylor, S; Johnson, D; Livingston, R; Komaki, R; Emami, B; Curran, W; Byhardt, R; Dar, AR; Turrisi, A
      Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

      CHEST
    80. Kerbrat, P; Lefeuvre, C
      Aromatase inhibitors: a review of clinical trials

      BULLETIN DU CANCER
    81. Windbichler, GH; Hausmaninger, H; Stummvoll, W; Graf, AH; Kainz, C; Lahodny, J; Denison, U; Muller-Holzner, E; Marth, C
      Interferon gamma in the first-line therapy of ovarian cancer: a randomizedphase III trial

      BRITISH JOURNAL OF CANCER
    82. Rosenthal, MA
      Advances in the management of prostate cancer

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    83. Seidenfeld, J; Samson, DJ; Hasselblad, V; Aronson, N; Albertsen, PC; Bennett, CL; Wilt, TJ
      Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis

      ANNALS OF INTERNAL MEDICINE
    84. Yeh, KA; Jillella, AP; Wei, JP
      Surgery for T4 breast carcinoma: Implications for local control

      AMERICAN SURGEON
    85. Herrin, VE; Thigpen, JT
      Chemotherapy for ovarian cancer: Current concepts

      SEMINARS IN SURGICAL ONCOLOGY
    86. Kirita, T; Ohgi, K; Shimooka, H; Yamanaka, Y; Tatebayashi, S; Yamamoto, K; Mishima, K; Sugimura, M
      Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results

      ORAL ONCOLOGY
    87. Ragaz, J
      Status of aromatase inhibitors in relation to other breast cancer treatment modalities

      ENDOCRINE-RELATED CANCER
    88. Ferro, VA; Stimson, WH
      Anti-gonadotropin releasing hormone vaccines and their potential use in the treatment of hormone-responsive cancers

      BIODRUGS
    89. Choti, MA; Bulkley, GB
      Management of hepatic metastases

      LIVER TRANSPLANTATION AND SURGERY
    90. Nathu, RM; Mendenhall, WM; Parsons, JT; Mancuso, AA; Carroll, RR
      Induction chemotherapy and radiation therapy for T4 oropharyngeal carcinoma

      RADIATION ONCOLOGY INVESTIGATIONS
    91. Garcia, ED; Santolaya, R; Requena, T
      Treatment of malignant melanoma

      ANNALS OF PHARMACOTHERAPY
    92. Robertson, JFR; Willsher, PC; Winterbottom, L; Blamey, RW; Thorpe, S
      Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer

      EUROPEAN JOURNAL OF CANCER
    93. Osoba, D
      What has been learned from measuring health-related quality of life in clinical oncology

      EUROPEAN JOURNAL OF CANCER
    94. Vincent, M; Labianca, R; Harper, P
      Which 5-fluorouracil regimen? - the great debate

      ANTI-CANCER DRUGS
    95. Wils, J; van Geuns, H; Stoot, J; Bergmans, M; Boschma, F; Bron, H; Degen, J; Erdkamp, F; van Erp, J; Haest, J; Iding, R; Lalisang, F; de Pree, N; de Rooy, C; Snijders, M; Schepers, J; Vreeswijk, J; Wals, J; Werter, M; Wetzels, L; Smeets, J; Schouten, L
      Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial ofthe Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg

      ANTI-CANCER DRUGS
    96. Stremetzne, S; Streit, M; Kreuser, ED; Schunack, W; Jaehde, U
      Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer

      PHARMACY WORLD & SCIENCE
    97. Khaled, HM; Zekri, ZK; Mokhtar, N; Ali, NM; Darwish, T; Elattar, I; Gaafar, R; Moawad, MS
      A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term results

      ANNALS OF ONCOLOGY
    98. Juretic, A; Sobat, H; Samija, M
      Combined modality therapy of non-small cell lung cancers

      ANNALS OF ONCOLOGY
    99. Cmelak, AJ; Murphy, BA; Day, T
      Combined-modality therapy for locoregionally advanced head and neck cancer

      ONCOLOGY-NEW YORK
    100. Adelstein, DJ
      Induction chemotherapy in head and neck cancer

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 23:36:12